Lantheus Holdings, Inc. (LNTH) Reaches $14.18 After 9.00% Up Move; Tybourne Capital Management Hk LTD Increased Its Salesforce Com (CRM) Holding

May 24, 2018 - By Vivian Currie

salesforce.com, inc. (NYSE:CRM) Logo

The stock of Lantheus Holdings, Inc. (NASDAQ:LNTH) is a huge mover today! The stock increased 3.85% or $0.525 during the last trading session, reaching $14.175. About 201,368 shares traded. Lantheus Holdings, Inc. (NASDAQ:LNTH) has risen 30.04% since May 24, 2017 and is uptrending. It has outperformed by 18.49% the S&P500.The move comes after 6 months positive chart setup for the $542.63M company. It was reported on May, 24 by Barchart.com. We have $15.45 PT which if reached, will make NASDAQ:LNTH worth $48.84M more.

Tybourne Capital Management Hk Ltd increased Salesforce Com Inc (CRM) stake by 27.78% reported in 2017Q4 SEC filing. Tybourne Capital Management Hk Ltd acquired 945,000 shares as Salesforce Com Inc (CRM)’s stock rose 10.89%. The Tybourne Capital Management Hk Ltd holds 4.35M shares with $444.34 million value, up from 3.40 million last quarter. Salesforce Com Inc now has $95.48B valuation. The stock increased 0.34% or $0.43 during the last trading session, reaching $128.52. About 1.85M shares traded. salesforce.com, inc. (NYSE:CRM) has risen 39.46% since May 24, 2017 and is uptrending. It has outperformed by 27.91% the S&P500.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company has market cap of $542.63 million. The Company’s principal products include DEFINITY, an ultrasound contrast imaging agent for use in patients with suboptimal echocardiograms; TechneLite, a self-contained system or generator of technetium used by radiopharmacies to prepare various nuclear imaging agents; and Xenon, a radiopharmaceutical gas used to assess pulmonary function and imaging of cerebral blood flow. It has a 4.47 P/E ratio. The firm also offers injectable technetium-labeled imaging agents, including Cardiolite, used in myocardial perfusion imaging procedures; and Neurolite, which is used to identify the area in the brain where blood flow has been blocked or reduced due to stroke.

Among 6 analysts covering Lantheus Holdings (NASDAQ:LNTH), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Lantheus Holdings had 16 analyst reports since August 31, 2015 according to SRatingsIntel. The stock of Lantheus Holdings, Inc. (NASDAQ:LNTH) earned “Neutral” rating by Credit Suisse on Friday, September 23. The firm earned “Buy” rating on Tuesday, October 10 by Jefferies. Jefferies maintained the shares of LNTH in report on Friday, November 3 with “Buy” rating. The rating was maintained by Credit Suisse with “Neutral” on Friday, November 3. Jefferies maintained the stock with “Buy” rating in Monday, August 29 report. As per Thursday, November 2, the company rating was upgraded by Wells Fargo. The stock of Lantheus Holdings, Inc. (NASDAQ:LNTH) earned “Buy” rating by Jefferies on Thursday, June 29. The firm has “Neutral” rating by Credit Suisse given on Wednesday, August 2. As per Wednesday, February 24, the company rating was maintained by RBC Capital Markets. The stock has “Neutral” rating by Robert W. Baird on Monday, August 31.

Another recent and important Lantheus Holdings, Inc. (NASDAQ:LNTH) news was published by Seekingalpha.com which published an article titled: “Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q1 2018 Results – Earnings Call Transcript” on May 03, 2018.

Analysts await Lantheus Holdings, Inc. (NASDAQ:LNTH) to report earnings on August, 7. They expect $0.21 earnings per share, down 50.00% or $0.21 from last year’s $0.42 per share. LNTH’s profit will be $8.04M for 16.88 P/E if the $0.21 EPS becomes a reality. After $0.22 actual earnings per share reported by Lantheus Holdings, Inc. for the previous quarter, Wall Street now forecasts -4.55% negative EPS growth.

Since December 11, 2017, it had 4 insider purchases, and 174 selling transactions for $134.27 million activity. On Thursday, February 22 the insider Hawkins Mark J sold $86,241. Shares for $1.23M were sold by BLOCK KEITH. 129 shares were sold by Roos John Victor, worth $14,462 on Thursday, February 15. The insider Benioff Marc sold 10,000 shares worth $1.17 million. 530 salesforce.com, inc. (NYSE:CRM) shares with value of $61,411 were sold by Harris Parker. 940 shares were sold by Martinez Maria, worth $105,957 on Friday, January 26. $11.36 million worth of salesforce.com, inc. (NYSE:CRM) was sold by Dayon Alexandre.

Investors sentiment decreased to 1.19 in Q4 2017. Its down 0.15, from 1.34 in 2017Q3. It fall, as 39 investors sold CRM shares while 274 reduced holdings. 110 funds opened positions while 261 raised stakes. 608.21 million shares or 0.25% less from 609.74 million shares in 2017Q3 were reported. Cetera Advisor Networks Ltd Limited Liability Company owns 9,749 shares. Jnba Fincl holds 0.04% of its portfolio in salesforce.com, inc. (NYSE:CRM) for 1,828 shares. The Brazil-based Bw Gestao De Investimentos Ltda has invested 0.18% in salesforce.com, inc. (NYSE:CRM). Boston Advisors Ltd Limited Liability Company reported 0.01% of its portfolio in salesforce.com, inc. (NYSE:CRM). Oppenheimer And Company invested in 0.11% or 40,163 shares. Mariner Wealth Advsr Ltd Llc invested in 3,425 shares or 0.01% of the stock. Johnson Investment Counsel Incorporated has invested 0.12% of its portfolio in salesforce.com, inc. (NYSE:CRM). Shine Investment Advisory Services accumulated 1,585 shares. Endowment Management Limited Partnership has invested 0.51% in salesforce.com, inc. (NYSE:CRM). Old Mutual Customised Solutions (Proprietary) Limited stated it has 32,894 shares or 0.34% of all its holdings. Parametric Portfolio Associates Ltd holds 0.2% of its portfolio in salesforce.com, inc. (NYSE:CRM) for 1.99 million shares. De Burlo Grp stated it has 3.24% in salesforce.com, inc. (NYSE:CRM). Rafferty Asset Mngmt Limited Liability Com holds 0.02% or 12,838 shares in its portfolio. Ballentine Prtnrs Lc, Massachusetts-based fund reported 11,018 shares. Private Advisor Limited Liability Corp has invested 0.04% in salesforce.com, inc. (NYSE:CRM).

More notable recent salesforce.com, inc. (NYSE:CRM) news were published by: Bizjournals.com which released: “Salesforce unveils new offices in San Francisco’s tallest building, Salesforce Tower” on May 22, 2018, also Prnewswire.com with their article: “Salesforce Positioned as a Leader in the 2018 Magic Quadrant for CRM Customer Engagement Center for Tenth …” published on May 24, 2018, Fool.com published: “Salesforce.com Won’t Be Running Out of Steam Anytime Soon” on May 20, 2018. More interesting news about salesforce.com, inc. (NYSE:CRM) were released by: Forbes.com and their article: “What To Watch For In Salesforce’s Q1 Earnings” published on May 16, 2018 as well as Investorplace.com‘s news article titled: “Wall Street’s Negative Reaction to NetApp Inc. Earnings Is Wrong” with publication date: May 24, 2018.

salesforce.com, inc. (NYSE:CRM) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>